Washington Post: What you need to know about the dry shampoo recall
UC expert discusses benzene
Unilever has issued a voluntary recall of more than a dozen aerosol dry shampoos due to potentially "elevated levels" of benzene in the products. Benzene is a naturally occurring chemical that is classified as a human carcinogen at high levels of prolonged exposure.
Kelly Dobos, adjunct professor at the University of Cincinnati's James L. Winkle College of Pharmacy and a cosmetic chemist, told the Washington Post benzene is "certainly dangerous," but people are routinely exposed to the chemical every day in trace amounts.
“It’s a trace contaminant,” Dobos said. “The cosmetic companies have toxicologists on staff. They do extensive research to ensure their products are safe.”
Dobos recommended using all aerosol products in well-ventilated areas with windows open.
Read the Washington Post article about the initial recall.
Read the Washington Post follow-up article featuring additional comments from Dobos.
Featured photo of some of the dry shampoo brands included in the recall courtesy of the Food and Drug Administration.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.